ShareValue scores for 600056.SHG: Valuation 73, Quality 34, Growth 33, Health 40.

600056.SHG
SSE

China Meheco Co Ltd

CN¥9.40(+2.17%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

12% to 28%
Valuation
73
Undervalued
Price vs Value
Quality
34
Weak
Business Strength
Growth
33
Weak
Revenue & Earnings
Health
40
Moderate
Financial Stability
Momentum
27
Bearish
Price Trend

Company Details

About

China Meheco Group Co., Ltd. operates in pharmaceutical industry in China and internationally. The company is involved in international trade of pharmaceuticals, including pharmaceutical preparations, drug substances, intermediates, medical devices, medical consumables, Chinese medicinal materials, and extracts; and pharmaceutical commerce business. It also provides supply chain services, such as sales agency, logistics and distribution, warehousing, equipment bidding, repair and maintenance, clinical value promotion, department planning, design, co-construction, operation and maintenance, SPD, and other services for various areas comprising vascular interventional therapy, non-interventional therapy, orthopedic implantation, neurosurgery, electrophysiology, pacemakers, extracorporeal circulation and blood purification, ophthalmology, and stomatology. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular and cerebrovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic and analgesics, and other therapeutic areas, as well as Chinese herbal materials and prepared slices. The company was founded in 1983 and is based in Beijing, China. Address: Apartment B, General Times Center, Building 1, Beijing, China, 100061

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026